Committee advances 340B reporting and fee framework amid debate over fees and rural impact
The committee reported out Engrossed Second Substitute Senate Bill 59‑81 after adopting a striking amendment establishing HCA filing fees and a 340B reporting account; multiple amendments to remove fees, require 90% of revenues for patient care, or limit contract pharmacies to rural areas failed amid debate over federal preemption, transparency and litigation risk.
The full story
The Health Care and Wellness committee on Feb. 25 advanced Engrossed Second Substitute Senate Bill 59‑81, a comprehensive package of reporting and fee provisions for the federal 340B drug pricing program, after adopting a striking amendment that sets HCA authority for fees, creates a dedicated 340B program reporting account, and requires certain aggregate reporting.
Sign up to keep reading.
Your free newsletter brings you what your city council, county, and school board discussed and decided.
Keep reading for free
Create a free account to finish this story and see the video, transcript and key details.
Continue with GoogleContinue with emailAlready have an account? Log in